Área de Sócio

XXVI Congresso Português de Aterosclerose


XXVI Congresso Português de Aterosclerose

87th EAS Congress


87th EAS Congress

Hipercolesterolemia Familiar (HF)

 

Materiais informativos

Hipercolesterolemia Familiar (HF)

Desenvolvidos pelo “International FH Paediatric Register”.

Uma cortesia do Grupo de Investigação Cardiovascular do INSA para chegar as famílias com crianças com FH para que melhor compreendam a sua doença e vivam melhor com ela.

Foram desenvolvidos para idades diferentes com conteúdos adaptados:

terça, 13 novembro 2018 09:33

Depressão e inflamação. Uma associação deletéria nos homens ingleses

No Estudo Longitudinal Inglês do Envelhecimento foram medidos a proteína C-reativa (PCR) e sintomas depressivos em 5328 homens e mulheres entre 52 e 89 anos. No trabalho publicado no Psychol Med. 2018 Sep 17:1-11, a combinação de sintomas depressivos e aumento da inflamação subclínica conferem um considerável aumento no risco de mortalidade por Doença Cardiovascular apenas nos homens. Esses efeitos parecem ser independentes, sugerindo um papel aditivo.

Combined influence of depressive symptoms and systemic inflammation on all-cause and cardiovascular mortality: evidence for differential effects by gender in the English Longitudinal Study of Ageing.

Lawes S(1), Demakakos P(1), Steptoe A(1), Lewis G(2), Carvalho LA(3).

BACKGROUND: Depressive symptoms and inflammation are risk factors for cardiovascular disease (CVD) and mortality. We investigated the combined association of these factors with the prediction of CVD and all-cause mortality in a representative cohort of older men and women.

METHODS: We measured C-reactive protein (CRP) and depressive symptoms in 5328 men and women aged 52-89 years in the English Longitudinal Study of Ageing. Depressive symptoms were measured using the eight-item Centre for Epidemiological Studies Depression Scale. CRP was analysed from peripheral blood. Mortality was ascertained from national registers and associations with depressive symptoms and inflammation were estimated using Cox proportional hazard models.

RESULTS: We identified 112 CVD related deaths out of 420 all-cause deaths in men  and 109 CVD related deaths out of 334 all-cause deaths in women over a mean follow-up of 7.7 years. Men with both depressive symptoms and high CRP (3-20 mg/L) had an increased risk of CVD mortality (hazard ratio; 95% confidence interval: 3.89; 2.04-7.44) and all-cause mortality (2.40; 1.65-3.48) after adjusting for age, socioeconomic variables and health behaviours. This considerably exceeds the risks associated with high CRP alone (CVD 2.43; 1.59-3.71, all-cause 1.49; 1.20-1.84). There was no significant increase in mortality risk associated with depressive symptoms alone in men. In women, neither depressive symptoms or inflammation alone or the combination of both significantly predicted CVD or all-cause mortality.

CONCLUSIONS: The combination of depressive symptoms and increased inflammation confers a considerable increase in CVD mortality risk for men. These effects appear to be independent, suggesting an additive role.

Psychol Med. 2018 Sep 17:1-11.